يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Alexander S Semikhin"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    دورية أكاديمية
    An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine 'Sputnik Light' for prevention of coronavirus infection in healthy adults

    المؤلفون: Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)

    مصطلحات موضوعية: Public aspects of medicine, RA1-1270

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2666776221002271; https://doaj.org/toc/2666-7762

    URL الوصول: https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d

    Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial

    المؤلفون: Eugene I Gusev, Mikhail Yu Martynov, Alexey A Nikonov, Nikolay A Shamalov, Michail P Semenov, Eugene A Gerasimets, Elena B Yarovaya, Andrey M Semenov, Alexander I Archakov, Sergey S Markin, Sergey B Aksentiev, Denis S. Yunevich, Andrey M Alasheev, Olga V Androfagina, Vladimir V Bobkov, Ksenia V Choroshavina, Janna Yu Chefranova, Yuriy A Lykov, Svetlana E Chuprina, Andrey A Vorobev, Alexey V Dobrovolskiy, Ulukpan A Elemanov, Sergey A Fedaynin, Vladimir I Gorbachev, Ivan V Korobeinikov, Irina V Greshnova, Larisa L Korsunskaya, Anastasiya A Nikonova, Vasily A Kudinov, Rafael I Artyushev, Vladimir A Kutsenko, Valentina N Nesterova, Alexey A Nizov, Alexey I Girivenko, Alexey A Orlovsky, Eduard A Ponomarev, Dmitriy V Popov, Sergey A Pribylov, Alexander S Semikhin, Ludmila V Timchenko, Olga N Jadan, Sergey A Zakharov, Alexander N Chirkov, Natalya V Zhukovskaya

    المصدر: The Lancet Neurology. 20:721-728

    مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, business.industry, Population, Staphylokinase, Odds ratio, Emergency department, law.invention, Randomized controlled trial, Equivalence Trial, law, Modified Rankin Scale, Internal medicine, medicine, Neurology (clinical), business, Adverse effect, education

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9ce875c314c297bce445455e2b16b79b
    https://doi.org/10.1016/s1474-4422(21)00210-6

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  3. 3
    One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow

    المؤلفون: D. A. Kleymenov, Anna V. Kovyrshina, Nadezhda L. Lubenets, Natalia A. Nikitenko, Sergei V. Borisevich, Alexander S. Semikhin, Elizaveta A. Tokarskaya, Daria M. Grousova, Andrey Pochtovyi, M M Shmarov, Dmitry V. Shcheblyakov, Olga Popova, Shchetinin Am, Tatiana A Ozharovskaya, Andrey Komissarov, Evgeniia N. Bykonia, Alina S. Dzharullaeva, Dmitry Lioznov, Alexander L. Gintsburg, Artem P. Tkachuk, A. I. Tukhvatulin, Denis Y. Logunov, Nadezhda P. Kuznetsova, Liubov I. Popova, Olga V. Zubkova, Inna V. Dolzhikova, Lyudmila Vasilchenko, Elena V. Shidlovskaya, Alina S. Erokhova, E. P. Mazunina, Boris S. Naroditsky, Alexander Tsybin, Elizaveta V. Divisenko, Vladimir A. Gushchin, Daria Danilenko, Fatima M. Izhaeva

    مصطلحات موضوعية: Delta, Vaccination, Immunization, business.industry, Incidence (epidemiology), Pandemic, Medicine, business, Vaccine efficacy, Virology, Confidence interval, Viral vector

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7f145807fe93e4a55dadded1a8a6b758
    https://doi.org/10.1101/2021.10.08.21264715

    أضف إلى المفضلة
  4. 4
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

    المؤلفون: A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya

    المصدر: The Lancet
    Lancet (London, England)

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, COVID-19 Vaccines, Immunization, Secondary, 030204 cardiovascular system & hematology, Placebo, Antibodies, Viral, Injections, Intramuscular, Moscow, law.invention, Russia, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, medicine, Data monitoring committee, Humans, 030212 general & internal medicine, Case report form, Vaccines, Synthetic, business.industry, SARS-CoV-2, COVID-19, Articles, General Medicine, Middle Aged, Interim analysis, Vaccine efficacy, Clinical trial, Vaccination, Spike Glycoprotein, Coronavirus, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  5. 5
    An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults

    المؤلفون: Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: SSRN Electronic Journal.

    مصطلحات موضوعية: Vaccination, Clinical trial, medicine.medical_specialty, Cellular immunity, Tolerability, business.industry, Immunity, Internal medicine, Immunogenicity, Medicine, Seroconversion, business, Adverse effect

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::46dd4f7e36c0425bc50de16bb4665594
    https://doi.org/10.2139/ssrn.3886430

    أضف إلى المفضلة
  6. 6
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

    المؤلفون: Tatiana A Ozharovskaya, Nadezhda L. Lubenets, Sergei V. Borisevich, Alexander S. Semikhin, Daria M. Grousova, Andrei G. Botikov, Yana V. Simakova, Fatima M. Izhaeva, Alina S. Erokhova, Denis I. Zrelkin, Olga V. Zubkova, Irina A Favorskaya, Elena A Smolyarchuk, Boris S. Naroditsky, M M Shmarov, Natalia A. Nikitenko, Alina S. Dzharullaeva, Alexander L. Gintsburg, Morozova Lf, Daria A. Egorova, Evgeny V Kryukov, Dmitry V. Shcheblyakov, Olga Popova, Denis Y. Logunov, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Amir I Tukhvatullin, Elizaveta A. Tokarskaya, Ilias B Esmagambetov, Vladimir F Babira, Anna V. Kovyrshina, Daria V Voronina

    المصدر: Yana Simakova
    Lancet (London, England)
    The Lancet

    مصطلحات موضوعية: medicine.medical_specialty, Cellular immunity, business.industry, Immunogenicity, Viral Vaccine, Articles, General Medicine, 030204 cardiovascular system & hematology, Vaccination, 03 medical and health sciences, 0302 clinical medicine, Immunity, Internal medicine, Humoral immunity, medicine, 030212 general & internal medicine, Seroconversion, business, Adverse effect

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b04ada67ad427528778d88936c6006e

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء